Click on the plus icon to show bio.
Bonnie Labosky: President and CEO
Bonnie has served as the CEO of Respicardia® since its inception in 2006 (as Cardiac Concepts). Her tenure includes several corporate executive positions at Welch Allyn, Medtronic, and SPSS. Prior to joining Respicardia®, Bonnie served at Welch Allyn as Group Vice President, where she managed a number of business units and international sales and operations. At Medtronic, as Vice President and General Manager, she managed businesses including Micro Interventional Systems and Heart Failure where the first Cardiac Resynchronization Therapy using an implantable device was developed. Also at Medtronic, Bonnie led several divisions dedicated to developing the technical components of implantable devices including software, batteries and capacitors, and leads. Bonnie received a B.A. in mathematics from Mercy Hurst College, an M.A. in mathematics from the University of Notre Dame, and an M.S. in computer science from the University of Minnesota.
Robin Germany, M.D.: Chief Medical Officer
Dr. Robin Germany joined Respicardia®, Inc. in 2008, coming from the University of Oklahoma where she was the Director of Heart Failure Treatment and Medical Director of the Heart, Lung and Vascular Clinic for 5 years. She followed her training in cardiovascular diseases at the University of Oklahoma with additional training in heart failure and electrophysiology. Her research focused on utilizing implantable devices to improve the care of heart failure patients. While serving as Chief Medical Officer for Respicardia®, Dr. Germany retains her title of Clinical Assistant Professor at the University of Oklahoma.
Tim Hauch: Chief Financial Officer
Tim came to Respicardia®, Inc. in 2010. He leads financial and business development operations at Respicardia®, bringing his industry expertise from his role as Vice President of Business Development with start-up super Dimension, along with seventeen years at Medtronic. His prior roles included responsibilities for identifying key growth markets and defining acquisition targets, as well as leading cross-functional teams through acquisition, investment, license, divestiture and development transactions. Tim’s breadth of experience encompasses both public and private M&A transactions as well as both sides of strategic investments. He received a B.A. from the University of Wisconsin-Oshkosh and earned an M.B.A. from the University of Chicago Booth School of Business. Tim also passed the CPA exam.
Todd Goblish: Vice President of Research and Development
Todd Goblish joined Respicardia®, Inc. in February 2008. His extensive medical device experience in implantables, neurostimulation and respiration prepared him well to lead the research, development and operations of the remedē® System. Todd’s prior experience includes five years as VP of R&D at Pulmonetic Systems whose product successes led to their acquisition by Viasys Healthcare, followed by Cardinal Health. Prior to Pulmonetic Systems, Todd held various engineering management positions over nine years with the Cardiac Rhythm Management and Neurological Divisions of Medtronic. He holds a B.S. in Electrical Engineering from Marquette University and an M.S. in Computer Engineering from National Technological University.
Linda Nelson: Vice President Clinical Affairs
Linda joined Respicardia®, Inc. in 2014 bringing over 15 years of medical device experience. Prior to Respicardia®, Linda was the Director of Clinical in AF Solutions at Medtronic where she participated in the acquisition of CryoCath and Ablation Frontiers, leading the clinical group through PMA submissions that resulted in approval of the Cryoballoon for paroxysmal AF. Linda has held various leadership and research roles in heart failure, heart transplant, electrophysiology, and atrial fibrillation. Linda received a B.S.N. from St. Olaf College in Northfield, MN and an M.B.A. from the University of St. Thomas.